The U.S. Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly. The therapy is still in test to establish its safety and effectiveness. It is similar to a treatment that President Donald Trump took after coronavirus infection last month.
The drug, called bamlanivimab, may help clear the coronavirus sooner, suggests the early results. Additionally, it possibly cut hospitalizations in people with mild to moderate Covid-19, the AP report said.
Earlier, the U.S. government reached an agreement to buy and supply the drug.
The new drug therapy offers a promising new approach to prevent serious disease and death from Coronavirus infection. According to the experts, the infused drugs could serve as a therapeutic bridge to help manage the virus until vaccines are widely available, AP reports.
The laboratory-made drug is versions of antibodies and blood proteins. Which the body creates to help target and eliminate foreign infections. The new therapies are concentrated versions of the antibodies proving most effective against the virus in patients.